| | | 62640 | | 06.11.2012 | | Sandoz Pharmaceuticals AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Co-Irbesartan Sandoz 150/12,5 mg | Filmtabletten | Filmtabletten (Irbesartan 150 mg, Hydrochlorothiazidum 12.5 mg) | C09DA04 | PI | | 02 | Co-Irbesartan Sandoz 300/12,5 mg | Filmtabletten | Filmtabletten (Irbesartan 300 mg, Hydrochlorothiazidum 12.5 mg) | C09DA04 | PI | | 03 | Co-Irbesartan Sandoz 300/25 mg | Filmtabletten | Filmtabletten (Irbesartan 300 mg, Hydrochlorothiazidum 25 mg) | C09DA04 | PI |
|
|
